ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Total Number of Shares Composing the Share Capital
ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Total Number of Shares Composing the Share Capital
(Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)
Regulatory News:
ABL Diagnostics (Paris:ABLD)
Date
ABL Diagnostics: Sale of a new block of shares by its main shareholder ABL
ABL Diagnostics: Ordinary and Extraordinary General Meeting of June 30, 2026 – Terms for Making Available or Consulting…
ABL Diagnostics Proposes a Significant Increase in Its Dividend for FY2025
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2026
Carmila: Information Concerning the Total Number of Voting Rights and Share
ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France
